Clinical Trials Browser

Phase 1/2 × Withdrawn × motesanib diphosphate × Clear all

NCT01349088 2025-05-02

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms